ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » Internal Medicine

Top Internal Medicine Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JERRY BENFIELD MD

Internal Medicine

66,299

$4.01M

2787
1865 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

40%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $59

SURESH NAIR M.D.

Internal Medicine

54,029

$2.99M

1285
954 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $59

MITCHELL WICKER MD

Internal Medicine

44,763

$2.57M

945
560 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

30%
patients receiving schedule three controlled substances

Avg: 17%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $59

ANITA CORNETT MD

Internal Medicine

43,974

$3.02M

972
602 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

36%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $59

ANTHONY CARTER MD

Internal Medicine

37,440

$1.84M

762
511 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

34%
patients receiving schedule three controlled substances

Avg: 17%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $59

BARRY HARDISON MD

Internal Medicine

37,199

$2.22M

1168
717 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

38%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $59

JAMES CHANEY M.D.

Internal Medicine

36,799

$2.06M

732
245 are 65+

35%
patients receiving schedule two controlled substances

Avg: 5%

45%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $59

CARMEL PERSON MD

Internal Medicine

36,231

$2.15M

763
646 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

29%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $59

SHERRELL ROBERTS MD

Internal Medicine

36,219

$1.71M

920
610 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $59

WILLIAM TRAVIS MD

Internal Medicine

35,488

$1.75M

1016
839 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $59

BOBBY TURNER M.D.

Internal Medicine

35,056

$2.08M

871
719 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $59

LEE SPARKS MD

Internal Medicine

35,048

$1.77M

1142
856 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $59

NANCY MORRIS M.D.

Internal Medicine

34,989

$2.22M

927
719 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $59

JESSE WALLACE M.D.

Internal Medicine

34,384

$1.81M

900
766 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $59

DANNY BUTLER MD

Internal Medicine

33,960

$1.86M

1341
1047 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $59

PRAVIN AVULA MD

Internal Medicine

32,108

$1.76M

841
642 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $59

MOHAMMAD AFZAL MD

Internal Medicine

31,956

$1.93M

624
394 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $59

HOUSAM HADDAD M.D.

Internal Medicine

31,698

$1.54M

821
605 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

32%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $59

STEVEN MORTON M.D.

Internal Medicine

30,871

$1.97M

803
555 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

33%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $59

WILLIAM KIRK M.D.

Internal Medicine

30,264

$1.88M

664
471 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $59

NIRAV SHETH MD

Internal Medicine

29,906

$1.57M

984
776 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $59

JOSE ECHEVERRIA MD

Internal Medicine

29,746

$1.57M

711
354 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

47%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $59

SAMUEL DUNLANY MD

Internal Medicine

29,046

$1.4M

797
630 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $59

MOHAMMAD SHAHZAD M.D.

Internal Medicine

28,743

$1.71M

854
519 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $59

EDINA TORLAK MD

Internal Medicine

28,413

$1.97M

480
368 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $59

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank